A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the safety and tolerability of talquetamab when
administered in different combination regimens and to identify the safe dose(s) of
talquetamab combination regimens.